NDX
Home
Browse All Titles
Sign In
GoogleAnalytics
Browse All Titles
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
View All
RB
recommended phase 2 dose (RP2D)
Answer 16.1
Question 18.1
Drug Approval and Regulatory Issues
refractory multiple myeloma (RRMM)
regulatory T cells (Tregs)
retinoblastoma (RB)
DNA Repair, Apoptotic Pathways, CDK Inhibitors
Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer
RFC
ribonucleotide reductase (RNR)
polymorphism in thiopurine methyltransferase (TPMT)
inhibition
purine analogs
R-ICE
rituximab, ifosfamide, carboplatin, etoposide (R-ICE)
Question 2.2
Alkylating Agents
Roc1
RRMM
Radioimmunoconjugates
RECIST
reduced folate carrier (RFC)
regulator of cullin 1 (Roc1)
response evaluation criteria in solid tumors (RECIST)
RNR
RP2D
Refresh
first
prev
1
30
select
next
last
Displaying items 1 - 18 of 18
Hi, I need to add below code